| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $180.7M | +11.2% | +27.5% |
| Cost of Revenue | $108.7M | +11.6% | +26.6% |
| Gross Profit | $72.0M | +10.5% | +29.0% |
| R&D Expense | $12.5M | +13.8% | +34.0% |
| SG&A Expense | $19.5M | +14.9% | +21.2% |
| Operating Income | -$11.1M | -7.5% | +3.7% |
| Interest Expense | $1.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.8M | +24.4% | +19.6% |
| Short-term Investments | $203.7M | -2.6% | -6.0% |
| Accounts Receivable | $98.9M | +13.8% | +25.9% |
| Inventory | $4.2M | -8.5% | +21.2% |
| Current Assets | $341.1M | +3.8% | +4.7% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.7M | — | — |
| Capital Expenditures | $19.9M | — | — |
| Investing Cash Flow | -$6.0M | — | — |
| Financing Cash Flow | $2.5M | — | — |
| Free Cash Flow | -$18.2M | — | — |
| +8.1% |
| +7.7% |
| Pre-tax Income | -$11.6M | +56.1% | -14.2% |
| Income Tax | -$17K | -112.5% | -156.7% |
| Net Income | -$11.6M | +56.1% | -13.7% |
| $698.9M |
| +1.7% |
| +3.0% |
| Current Liabilities | $94.1M | +12.0% | +32.8% |
| Total Liabilities | $425.8M | +2.5% | +17.7% |
| Stockholders' Equity | $272.0M | +0.6% | -13.7% |